Skip to the page

Data / Form D filings / Keraplast Manufacturing

Keraplast Manufacturing: Form D filing

Keraplast Manufacturing, a biotechnology company in Lincoln, New Zealand, filed a Form D with the SEC in 2024. The latest, on February 21, 2024, reports $1.3 million sold of a $1.3 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
CORNER OF SPRINGS ROAD AND GERALD ST., Lincoln, New Zealand, 7608
Phone
033259100
Industry
Biotechnology
Entity type
Other (New Zealand Incorporated Company)
Incorporated in
New Zealand
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2012473

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 21, 2024New notice$1,264,782$1,264,7821Dec 29, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Howard Stanley MooreExecutive Officer, Director
Edward Shihai LeeDirector
Timothy Howard HerringDirector
Robert Allen SmithDirector
Michael William SheaDirector

Every Form D from the week of Feb 19, 2024 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Keraplast Manufacturing reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.